(NASDAQ: ASRT) Assertio Holdings's forecast annual revenue growth rate of 0.13% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 35.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.15%.
Assertio Holdings's revenue in 2026 is $137,352,000.On average, 6 Wall Street analysts forecast ASRT's revenue for 2026 to be $721,060,086, with the lowest ASRT revenue forecast at $631,872,455, and the highest ASRT revenue forecast at $780,608,343. On average, 3 Wall Street analysts forecast ASRT's revenue for 2027 to be $817,184,319, with the lowest ASRT revenue forecast at $785,164,298, and the highest ASRT revenue forecast at $841,247,462.
In 2028, ASRT is forecast to generate $878,400,954 in revenue, with the lowest revenue forecast at $843,942,534 and the highest revenue forecast at $904,260,811.